Psychedelics
Psilocybin Treats Depression by Increasing the Number of Brain Connections, Study Finds
The magic mushroom compound appears to stimulate certain neurons in the brain to interconnect, an effect not seen in the brains of people on more conventional anti-depressants.
Psilocybin Users Are Less Likely to Develop an Opioid Addiction, Study Finds
Adults who have used psilocybin at some point in their lives are 30 percent less likely to develop problems with opioid use disorder, according to a new study from researchers at Harvard University.
Psychedelic Drug Users Are More Likely to Believe Plants and Objects Have Consciousness, Study Finds
One single psychedelic experience can change a person’s views on consciousness dramatically, to the point that they begin to attribute consciousness to more living and non-living things, according to a new study from Johns Hopkins Medicine.
Machine Learning Algorithm Maps Psychedelic Effects to Specific Regions of the Brain
Scientists are beginning to discover which parts of the brain are responsible for certain hallucinogenic sensations, with a little help from artificial intelligence.
Utah Governor Signs Bill to Study the Benefits of Psychedelic Therapy
Governor Spencer Cox signed the bill on Tuesday, March 22.
Little Evidence on How Psilocybin Therapy Interacts With Existing Psychiatric Treatments, Review Finds
Ahead of Oregon's psilocybin legalization initiative, researchers at Oregon Health & Science University reviewed the evidence base for the therapeutic use of the drug.
Oregon Psychedelics Regulator Resigns Over a Conflict of Interest
Back in November 2020, Oregon voters approved a ballot measure to legalize psilocybin mushrooms for therapy sessions.
Psychedelics 101: The Emergence, Regulatory Framework, & the Need for Quality Testing
Learn about the emergence of psychedelic drugs, their importance & how a Laboratory Information Management System (LIMS) can assure their quality testing.
Testing Psilocybin With Delic Labs' Eric Janusson
In a new Analytical Cannabis webinar held on March 8, Eric Janusson, lead chemist at the Vancouver-based Delic Labs, will present new methods being developed by Delic to produce accurate results for psilocybin quantitation. Here's what he had to say ahead of that webinar.
